Figure 2. Gefitinib enhances the sensitivity of MCF-7/TAM cells to TAM.
The inhibitory effects of 10 μg/mL Gefitinib, 1.5 μmol/L TAM, or 10 μg/mL Gefitinib plus 1.5 μmol/L TAM on MCF-7/TAM cell proliferation were evaluated. The data revealed that treatment with Gefitinib re-sensitisedMCF-7/TAM cells to TAM and inhibited cell proliferation. All the experiments were repeated three times.* denotes p < 0.05.